Ann Pediatr Endocrinol Metab.  2020 Jun;25(2):69-79. 10.6065/apem.2040064.032.

Deciphering short stature in children

Affiliations
  • 1Department of Pediatrics, University of Chieti, Chieti, Italy

Abstract

Short stature is a common reason for referral to pediatric endocrinologists. Multiple factors, including genetic, prenatal, postnatal, and local environmental factors, can impair growth. The majority of children with short stature, which can be defined as a height less than 2 standard deviation score below the mean, are healthy. However, in some cases, they may have an underlying relevant disease; thus, the aim of clinical evaluation is to identify the subset of children with pathologic conditions, for example growth hormone deficiency or other hormonal abnormalities, Turner syndrome, inflammatory bowel disease, or celiac disease. Prompt identification and management of these children can prevent excessive short stature in adulthood. In addition, a thorough clinical assessment may allow evaluation of the severity of short stature and likely growth trajectory to identify the most effective interventions. Consequently, appropriate diagnosis of short stature should be performed as early as possible and personalized treatment should be started in a timely manner. An increase in knowledge and widespread availability of genetic and epigenetic testing in clinical practice in recent years has empowered the diagnostic process and appropriate treatment for short stature. Furthermore, novel treatment approaches that can be used both as diagnostic tools and as therapeutic agents have been developed. This article reviews the diagnostic approach to children with short stature, discusses the main causes of short stature in children, and reports current therapeutic approaches and possible future treatments.

Keyword

Growth; Short stature; Child; Height; Anthropometric measurements; Auxology; Growth hormone therapy

Figure

  • Fig. 1. GH-IGF-1 axis. GH, growth hormone; GHRH, GH releasing hormone; IGF-1, insulin-like growth factor-1; IGFBP, IGF-binding protein; ALS, acid-labile subunit. , stimulatory; , inhibitory.

  • Fig. 2. Flow-chart for investigation of children with short stature. TSH, tyroid-stimulating hormone; IGF-1, insulinlike growth factor-1; GH, growth hormone; GHD, growth hormone deficiency; CDGP, constitutional delay of growth and puberty; ISS, idiopathic short stature. *Family and past medical history as: consanguinity, timing of puberty in the parents, birth history, abnormalities of fetal growth, perinatal complications, chronic disease, medication use, nutritional status, and psycho- social and cognitive development. **Using arm span, sitting height or upper-tolower segment ratios, body mass index, and measurement of head circumference (<4 years of age). ***Blood count, erythrocyte sedimentation rate, creatinine, electrolytes, bicarbonate, calcium, phosphate, alkaline phosphatase, albumin, TSH, and free T4, screening for coeliac disease; karyotype in girls.


Cited by  2 articles

Approach to Short Stature in Children and Adolescent
Hyo-Kyoung Nam
Ewha Med J. 2021;44(4):111-116.    doi: 10.12771/emj.2021.44.4.111.

Clinical validation of a deep-learning-based bone age software in healthy Korean children
Hyo-Kyoung Nam, Winnah Wu-In Lea, Zepa Yang, Eunjin Noh, Young-Jun Rhie, Kee-Hyoung Lee, Suk-Joo Hong
Ann Pediatr Endocrinol Metab. 2024;29(2):102-108.    doi: 10.6065/apem.2346050.025.


Reference

References

1. Collett-Solberg PF, Jorge AAL, Boguszewski MCS, Miller BS, Choong CSY, Cohen P, et al. Growth hormone therapy in children; research and practice - A review. Growth Horm IGF Res. 2019; 44:20–32.
Article
2. Cheetham T, Davies JH. Investigation and management of short stature. Arch Dis Child. 2014; 99:767–71.
Article
3. Baron J, Sävendahl L, De Luca F, Dauber A, Phillip M, Wit JM, et al. Short and tall stature: a new paradigm emerges. Nat Rev Endocrinol. 2015; 11:735–46.
Article
4. Ranke MB, Lindberg A; KIGS International Board. Earlyonset idiopathic growth hormone deficiency within KIGS. Horm Res. 2003; 60:18–21.
Article
5. Bidlingmaier M, Freda PU. Measurement of human growth hormone by immunoassays: current status, unsolved problems and clinical consequences. Growth Horm IGF Res. 2010; 20:19–25.
Article
6. Wagner IV, Paetzold C, Gausche R, Vogel M, Koerner A, Thiery J, et al. Clinical evidence-based cutoff limits for GH stimulation tests in children with a backup of results with reference to mass spectrometry. Eur J Endocrinol. 2014; 171:389–97.
Article
7. Stanley TL, Levitsky LL, Grinspoon SK, Misra M. Effect of body mass index on peak growth hormone response to provocative testing in children with short stature. J Clin Endocrinol Metab. 2009; 94:4875–81.
Article
8. Eskes SA, Tomasoa NB, Endert E, Geskus RB, Fliers E, Wiersinga WM. Establishment of reference values for endocrine tests. Part VII: growth hormone deficiency. Neth J Med. 2009; 67:127–33.
9. David A, Hwa V, Metherell LA, Netchine I, CamachoHübner C, Clark AJ, et al. Evidence for a continuum of genetic, phenotypic, and biochemical abnormalities in children with growth hormone insensitivity. Endocr Rev. 2011; 32:472–97.
Article
10. Albertsson-Wikland K, Rosberg S, Karlberg J, Groth T. Analysis of 24-hour growth hormone profiles in healthy boys and girls of normal stature: relation to puberty. J Clin Endocrinol Metab. 1994; 78:1195–201.
Article
11. Le Roith D, Bondy C, Yakar S, Liu JL, Butler A. The somatomedin hypothesis: 2001. Endocr Rev. 2001; 22:53–74.
Article
12. Hwa V, Oh Y, Rosenfeld RG. The insulin-like growth factor-binding protein (IGFBP) superfamily. Endocr Rev. 1999; 20:761–87.
Article
13. Ranke MB. Insulin-like growth factor binding-protein-3 (IGFBP-3). Best Pract Res Clin Endocrinol Metab. 2015; 29:701–11.
Article
14. Weber MM, Auernhammer CJ, Lee PD, Engelhardt D, Zachoval R. Insulin-like growth factors and insulinlike growth factor binding proteins in adult patients with severe liver disease before and after orthotopic liver transplantation. Horm Res. 2002; 57:105–12.
Article
15. Leung KC, Doyle N, Ballesteros M, Waters MJ, Ho KK. Insulin regulation of human hepatic growth hormone receptors: divergent effects on biosynthesis and surface translocation. J Clin Endocrinol Metab. 2000; 85:4712–20.
Article
16. Purandare A, Co Ng L, Godil M, Ahnn SH, Wilson TA. Effect of hypothyroidism and its treatment on the IGF system in infants and children. J Pediatr Endocrinol Metab. 2003; 16:35–42.
Article
17. Meinhardt UJ, Ho KK. Modulation of growth hormone action by sex steroids. Clin Endocrinol (Oxf). 2006; 65:413–22.
Article
18. Jansson UH, Kristiansson B, Magnusson P, Larsson L, Albertsson-Wikland K, Bjarnason R. The decrease of IGF-I, IGF-binding protein-3 and bone alkaline phosphatase isoforms during gluten challenge correlates with small intestinal inflammation in children with coeliac disease. Eur J Endocrinol. 2001; 144:417–23.
Article
19. Støving RK, Hangaard J, Hagen C, Flyvbjerg A. Low levels of the 150-kD insulin-like growth factor binding protein 3 ternary complex in patients with anorexia nervosa: effect of partial weight recovery. Horm Res. 2003; 60:43–8.
Article
20. Zhao Y, Xiao X, Frank SJ, Lin HY, Xia Y. Distinct mechanisms of induction of hepatic growth hormone resistance by endogenous IL-6, TNF-α, and IL-1β. Am J Physiol Endocrinol Metab. 2014; 307:E186–98.
Article
21. Choukair D, Hügel U, Sander A, Uhlmann L, Tönshoff B. Inhibition of IGF-I-related intracellular signaling pathways by proinflammatory cytokines in growth plate chondrocytes. Pediatr Res. 2014; 76:245–51.
Article
22. Nilsson O, Marino R, De Luca F, Phillip M, Baron J. Endocrine regulation of the growth plate. Horm Res. 2005; 64:157–65.
Article
23. Isaksson OG, Lindahl A, Nilsson A, Isgaard J. Mechanism of the stimulatory effect of growth hormone on longitudinal bone growth. Endocr Rev. 1987; 8:426–38.
Article
24. Wang J, Zhou J, Cheng CM, Kopchick JJ, Bondy CA. Evidence supporting dual, IGF-I-independent and IGF-Idependent, roles for GH in promoting longitudinal bone growth. J Endocrinol. 2004; 180:247–55.
Article
25. Mehta A, Hindmarsh PC, Stanhope RG, Turton JP, Cole TJ, Preece MA, et al. The role of growth hormone in determining birth size and early postnatal growth, using congenital growth hormone deficiency (GHD) as a model. Clin Endocrinol (Oxf). 2005; 63:223–31.
Article
26. Klammt J, Kiess W, Pfäffle R. IGF1R mutations as cause of SGA. Best Pract Res Clin Endocrinol Metab. 2011; 25:191–206.
Article
27. Grote FK, van Dommelen P, Oostdijk W, de Muinck Keizer-Schrama SM, Verkerk PH, Wit JM, et al. Developing evidence-based guidelines for referral for short stature. Arch Dis Child. 2008; 93:212–7.
Article
28. Hermanussen M, Cole J. The calculation of target height reconsidered. Horm Res. 2003; 59:180–3.
Article
29. Tanner JM, Goldstein H, Whitehouse RH. Standards for children's height at ages 2-9 years allowing for heights of parents. Arch Dis Child. 1970; 45:755–62.
30. WHO Multicentre Growth Reference Study Group. WHO Child Growth Standards based on length/height, weight and age. Acta Paediatr Suppl. 2006; 450:76–85.
31. Saari A, Sankilampi U, Hannila ML, Saha MT, Mäkitie O, Dunkel L. Screening of turner syndrome with novel auxological criteria facilitates early diagnosis. J Clin Endocrinol Metab. 2012; 97:E2125–32.
Article
32. Wehkalampi K, Vangonen K, Laine T, Dunkel L. Progressive reduction of relative height in childhood predicts adult stature below target height in boys with constitutional delay of growth and puberty. Horm Res. 2007; 68:99–104.
Article
33. Bhadada SK, Agrawal NK, Singh SK, Agrawal JK. Etiological profile of short stature. Indian J Pediatr. 2003; 70:545–7.
Article
34. Savage MO, Backeljauw PF, Calzada R, Cianfarani S, Dunkel L, Koledova E, et al. Early detection, referral, investigation, and diagnosis of children with growth disorders. Horm Res Paediatr. 2016; 85:325–32.
Article
35. Velayutham K, Selvan SSA, Jeyabalaji RV, Balaji S. Prevalence and etiological profile of short stature among school children in a South Indian Population. Indian J Endocrinol Metab. 2017; 21:820–2.
Article
36. Garg P. Short stature in Indian children: experience from a community level hospital. Sri Lanka J Child Health. 2004; 34:84–8.
Article
37. Chowdhury SP, Sarkar TK, Haldar D, Taraphdar P, Naskar TK, Sarkar GN. Short stature in children: experience from a tertiary care hospital in Kolkata, India. theHealth. 2011; 2:139–42.
38. Chen R, Shen S, Tu Y, Hong XIA, Hui WANG, Di-jing ZHI, et al. A cluste systematic sampling survey of body height distribution profile and the prevalence of short stature of urban and surburban children aged from 6 to 18 years in Shanghai. Chin J Evid Based Pediatr. 2009; 1:5–11.
39. Barrenäs ML, Bratthall A, Dahlgren J. The association between short stature and sensorineural hearing loss. Hear Res. 2005; 205:123–30.
Article
40. Xiang J, Liu W, Luo Y, Wang W, Li Y, Lin X, et al. Height standards and prevalence of short stature investigation for 5- to 18-year-old children in Wanzhou, Chongqing. J Third Mil Med Univ. 2014; 36:2221–4.
41. Wang Q, Liu DY, Yang LQ, Liu Y, Chen XJ. The epidemic characteristics of short stature in school students. Ital J Pediatr. 2015; 41:99.
Article
42. Lindsay R, Feldkamp M, Harris D, Robertson J, Rallison M. Utah Growth Study: growth standards and the prevalence of growth hormone deficiency. J Pediatr. 1994; 125:29–35.
Article
43. Voss LD, Mulligan J, Betts PR, Wilkin TJ. Poor growth in school entrants as an index of organic disease: the Wessex growth study. BMJ. 1992; 305:1400–2.
Article
44. Shiva S, Nikzad A. Etiology of short stature in East Azerbaijan Iran. Iran J Pediatr. 2009; 19:35–40.
45. Craig D, Fayter D, Stirk L, Crott R. Growth monitoring for short stature: update of a systematic review and economic model. Health Technol Assess. 2011; 15:iii–64.
Article
46. Moon JS. Secular trends of body sizes in Korean children and adolescents: from 1965 to 2010. Korean J Pediatr. 2011; 54:436–42.
Article
47. Sankilampi U, Saari A, Laine T, Miettinen PJ, Dunkel L. Use of electronic health records for automated screening of growth disorders in primary care. JAMA. 2013; 310:1071–2.
Article
48. de Muinck Keizer-Schrama SM. Consensus 'diagnostiek kleine lichaamslengte bij kinderen' Consensus 'diagnosis of short stature in children.' National Organization for Quality Assurance in Hospitals. Ned Tijdschr Geneeskd. 1998; 142:2519–25.
49. van Buuren S, Bonnemaijer-Kerckhoffs DJ, Grote FK, Wit JM, Verkerk PH. Many referrals under Dutch short stature guidelines. Arch Dis Child. 2004; 89:351–2.
Article
50. Stalman SE, Hellinga I, van Dommelen P, Hennekam RC, Saari A, Sankilampi U, et al. Application of the Dutch, Finnish and British Screening Guidelines in a cohort of children with growth failure. Horm Res Paediatr. 2015; 84:376–82.
Article
51. Oostdijk W, Grote FK, de Muinck Keizer-Schrama SM, Wit JM. Diagnostic approach in children with short stature. Horm Res. 2009; 72:206–17.
Article
52. Cohen P, Rogol AD, Deal CL, Saenger P, Reiter EO, Ross JL, et al. Consensus statement on the diagnosis and treatment of children with idiopathic short stature: a summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology Workshop. J Clin Endocrinol Metab. 2008; 93:4210–7.
Article
53. Collett-Solberg PF, Ambler G, Backeljauw PF, Bidlingmaier M, Biller BMK, Boguszewski MCS, et al. Diagnosis, genetics, and therapy of short stature in children: a growth hormone research society international perspective. Horm Res Paediatr. 2019; 92:1–14.
Article
54. Malaquias AC, Scalco RC, Fontenele EG, Costalonga EF, Baldin AD, Braz AF, et al. The sitting height/height ratio for age in healthy and short individuals and its potential role in selecting short children for SHOX analysis. Horm Res Paediatr. 2013; 80:449–56.
Article
55. Binder G, Renz A, Martinez A, Keselman A, Hesse V, Riedl SW, et al. SHOX haploinsufficiency and Leri-Weill dyschondrosteosis: prevalence and growth failure in relation to mutation, sex, and degree of wrist deformity. J Clin Endocrinol Metab. 2004; 89:4403–8.
56. Hisado-Oliva A, Garre-Vázquez AI, Santaolalla-Caballero F, Belinchón A, Barreda-Bonis AC, Vasques GA, et al. Heterozygous NPR2 mutations cause disproportionate short stature, similar to Léri-Weill dyschondrosteosis. J Clin Endocrinol Metab. 2015; 100:E1133–42.
57. Gravholt CH, Andersen NH, Conway GS, Dekkers OM, Geffner ME, Klein KO, et al. Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting. Eur J Endocrinol. 2017; 177:G1–70.
Article
58. Greulich WW, Pyle SI. Radiographic atlas of skeletal development of the hand and wrist. 2nd ed. Stanford (CA): Stanford University Press;1959.
59. Tanner JM, Healy MJR, Goldstein H, Cameron N. Assessment of skeletal maturity and prediction of adult height (TW3 Method). 3rd ed. London: WB Saunders;2001.
60. Gkourogianni A, Andrew M, Tyzinski L, Crocker M, Douglas J, Dunbar N, et al. Clinical characterization of patients with autosomal dominant short stature due to aggrecan mutations. J Clin Endocrinol Metab. 2017; 102:460–9.
Article
61. Geffner M, Lundberg M, Koltowska-Häggström M, Abs R, Verhelst J, Erfurth EM, et al. Changes in height, weight, and body mass index in children with craniopharyngioma after three years of growth hormone therapy: analysis of KIGS (Pfizer International Growth Database). J Clin Endocrinol Metab. 2004; 89:5435–40.
Article
62. Vasques GA, Funari MFA, Ferreira FM, Aza-Carmona M, Sentchordi-Montané L, Barraza-García J, et al. IHH gene mutations causing short stature with nonspecific skeletal abnormalities and response to growth hormone therapy. J Clin Endocrinol Metab. 2018; 103:604–14.
Article
63. Murray PG, Clayton PE, Chernausek SD. A genetic approach to evaluation of short stature of undetermined cause. Lancet Diabetes Endocrinol. 2018; 6:564–74.
Article
64. Wit JM, Oostdijk W, Losekoot M, van Duyvenvoorde HA, Ruivenkamp CA, Kant SG. Mechanisms in endocrinology: novel genetic causes of short stature. Eur J Endocrinol. 2016; 174:R145–73.
Article
65. Fayter D, Nixon J, Hartley S, Rithalia A, Butler G, Rudolf M, et al. Effectiveness and cost-effectiveness of heightscreening programmes during the primary school years: a systematic review. Arch Dis Child. 2008; 93:278–84.
Article
66. Chaler EA, Ballerini Ga, Lazzati JM, Maceiras M, Frusti M, Bergada I, et al. Cut-off values of serum growth hormone (GH) in pharmacological stimulation tests (PhT) evaluated in short-statured children using a chemiluminescent immunometric ass ay (ICMA) calibrated with the International Recombinant Human GH Standard 98/574. Clin Chem Lab Med. 2013; 51:e95. –7.
Article
67. Secco A, di Iorgi N, Napoli F, Calandra E, Ghezzi M, Frassinetti C, et al. The glucagon test in the diagnosis of growth hormone deficiency in children with short stature younger than 6 years. J Clin Endocrinol Metab. 2009; 94:4251–7.
Article
68. Tanaka T, Cohen P, Clayton PE, Laron Z, Hintz RL, Sizonenko PC. Diagnosis and management of growth hormone deficiency in childhood and adolescence--part 2: growth hormone treatment in growth hormone deficient children. Growth Horm IGF Res. 2002; 12:323–41.
69. Ranke MB, Wit JM. Growth hormone - past, present and future. Nat Rev Endocrinol. 2018; 14:285–300.
Article
70. Martínez AS, Domené HM, Ropelato MG, Jasper HG, Pennisi PA, Escobar ME, et al. Estrogen priming effect on growth hormone (GH) provocative test: a useful tool for the diagnosis of GH deficiency. J Clin Endocrinol Metab. 2000; 85:4168–72.
Article
71. Kalina MA, Kalina-Faska B, Gruszczyńska K, Baron J, Małecka-Tendera E. Usefulness of magnetic resonance findings of the hypothalamic-pituitary region in the management of short children with growth hormone deficiency: evidence from a longitudinal study. Childs Nerv Syst. 2012; 28:121–7.
Article
72. Lin YJ, Cheng CF, Wang CH, Liang WM, Tang CH, Tsai LP, et al. Genetic architecture associated with familial short stature. J Clin Endocrinol Metab. 2020; 105:dgaa131.
Article
73. Pedicelli S, Peschiaroli E, Violi E, Cianfarani S. Controversies in the definition and treatment of idiopathic short stature (ISS). J Clin Res Pediatr Endocrinol. 2009; 1:105–15.
Article
74. Pinto G, Cormier-Daire V, Le Merrer M, Samara-Boustani D, Baujat G, Fresneau L, et al. Efficacy and safety of growth hormone treatment in children with hypochondroplasia: comparison with an historical cohort. Horm Res Paediatr. 2014; 82:355–63.
Article
75. Cody JD, Semrud-Clikeman M, Hardies LJ, Lancaster J, Ghidoni PD, et al. Growth hormone benefits children with 18q deletions. Am J Med Genet A. 2005; 137:9–15.
Article
76. Garcia JM, Biller BMK, Korbonits M, Popovic V, Luger A, Strasburger CJ, et al. Macimorelin as a diagnostic test for adult GH deficiency. J Clin Endocrinol Metab. 2018; 103:3083–93.
Article
77. Allen DB, Backeljauw P, Bidlingmaier M, Biller BM, Boguszewski M, Burman P, et al. GH safety workshop position paper: a critical appraisal of recombinant human GH therapy in children and adults. Eur J Endocrinol. 2016; 174:P1–9.
Article
78. Chanson P, Cailleux-Bounacer A, Kuhn JM, Weryha G, Chabre O, Borson-Chazot F, et al. Comparative validation of the growth hormone-releasing hormone and arginine test for the diagnosis of adult growth hormone deficiency using a growth hormone assay conforming to recent international recommendations. J Clin Endocrinol Metab. 2010; 95:3684–92.
Article
79. Christiansen JS, Backeljauw PF, Bidlingmaier M, Biller BM, Boguszewski MC, Casanueva FF, et al. Growth Hormone Research Society perspective on the development of longacting growth hormone preparations. Eur J Endocrinol. 2016; 174:C1–8.
Article
80. Yuen KCJ, Miller BS, Biller BMK. The current state of long-acting growth hormone preparations for growth hormone therapy. Curr Opin Endocrinol Diabetes Obes. 2018; 25:267–73.
Article
81. Ornitz DM, Legeai-Mallet L. Achondroplasia: development, pathogenesis, and therapy. Dev Dyn. 2017; 246:291–309.
Article
82. Legeai-Mallet L. C-type natriuretic peptide analog as therapy for achondroplasia. Endocr Dev. 2016; 30:98–105.
Article
Full Text Links
  • APEM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr